Loading...
Loading...
PROF| Name | Value |
|---|---|
| Revenues | 2,233.0K |
| Cost of Revenue | 795.0K |
| Gross Profit | 1,438.0K |
| Operating Expense | -6,395.0K |
| Operating I/L | 7,833.0K |
| Other Income/Expense | -14,732.0K |
| Interest Income | 786.8K |
| Pretax | -6,899.0K |
| Income Tax Expense | 20.0K |
| Net Income/Loss | -6,919.0K |
Profound Medical Corp. is a commercial-stage medical device company specializing in the development of magnetic resonance guided ablation procedures for the treatment of prostate disease, uterine fibroids, and palliative pain. The company's lead product, the TULSA-PRO system, is utilized with magnetic resonance imaging scanners in hospitals and treatment facilities. Additionally, Profound Medical Corp. offers the Sonalleve therapeutic platform for the non-invasive treatment of uterine fibroids and palliative pain relief associated with bone metastases. These innovative medical devices generate revenue through sales to healthcare facilities and providers, offering advanced solutions for minimally invasive procedures and pain management.
